ResearcherUniversity of KochiActive in the last 2 years
Kaoru Furihata
Matched on ORCID iD 0009-0006-8169-3137; OpenAlex author ID A5064786109. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper · 2026: 3 papers
Papers 5
- Chemotherapy-induced CAF-associated stromal remodeling in a humanized stroma pancreatic ductal adenocarcinoma organoid xenograft model: a comparison between GP… Co-author DOI 10.1007/s13577-026-01443-8↗
- Inhibition of pancreatic cancer growth by an siRNA targeting SNORA22 and a folic acid-conjugated cationic oligopeptide. Co-author DOI 10.1007/s13577-026-01458-1↗
- A Pancreatic Ductal Adenocarcinoma Diagnostic System Using Serum Extracellular Vesicle Detection with Optimized Lectin Combination Using Machine Learning. Co-author DOI 10.3390/cancers18060924↗
- Inhibitory effects of the combination of rapamycin with gemcitabine plus paclitaxel on the growth of pancreatic cancer tumors. Co-author DOI 10.1007/s13577-024-01165-9↗
- Establishment of a mouse model of pancreatic cancer using human pancreatic cancer cell line S2-013-derived organoid. First author DOI 10.1007/s13577-022-00684-7↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Keisuke Taniuchi · 4 shared papers, 2022–2026 · strength 1.12
- Paper Chemotherapy-induced CAF-associated stromal remodeling in a humanized stroma pancreatic ductal adenocarcinoma organoid … DOI 10.1007/s13577-026-01443-8↗
- Paper Inhibitory effects of the combination of rapamycin with gemcitabine plus paclitaxel on the growth of pancreatic cancer … DOI 10.1007/s13577-024-01165-9↗
- Paper Inhibition of pancreatic cancer growth by an siRNA targeting SNORA22 and a folic acid-conjugated cationic oligopeptide. DOI 10.1007/s13577-026-01458-1↗
- Mutsuo Furihata · 4 shared papers, 2022–2026 · strength 1.05
- Paper Chemotherapy-induced CAF-associated stromal remodeling in a humanized stroma pancreatic ductal adenocarcinoma organoid … DOI 10.1007/s13577-026-01443-8↗
- Paper Inhibitory effects of the combination of rapamycin with gemcitabine plus paclitaxel on the growth of pancreatic cancer … DOI 10.1007/s13577-024-01165-9↗
- Paper A Pancreatic Ductal Adenocarcinoma Diagnostic System Using Serum Extracellular Vesicle Detection with Optimized Lectin … DOI 10.3390/cancers18060924↗
- Yuri Jobu · 1 shared paper, 2025 · strength 0.30
- Kazuhiro Hiyama · 1 shared paper, 2026 · strength 0.30
- Ayumi Kashiro · 1 shared paper, 2026 · strength 0.23
- Minoru Kitago · 1 shared paper, 2026 · strength 0.23
- Atsushi Kuno · 1 shared paper, 2026 · strength 0.23
- Sho Uemura · 1 shared paper, 2026 · strength 0.23
- Tatsuya Kawakami · 1 shared paper, 2026 · strength 0.23
- Yuko Kitagawa · 1 shared paper, 2026 · strength 0.23
- Yasuaki Kabe · 1 shared paper, 2026 · strength 0.23
- Kazufumi Honda · 1 shared paper, 2026 · strength 0.23
- Mitsunari Ogasawara · 1 shared paper, 2022 · strength 0.16
- Hideki Taniguchi · 1 shared paper, 2022 · strength 0.16
- Chiharu Tanaka · 1 shared paper, 2022 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.